Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027300
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2001-11-30
Brief Title:
Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Sponsor:
Biogen
Organization:
Biogen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-11
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01
Completion Date Type:
ACTUAL
First Submit Date:
2001-11-30
First Submit QC Date:
November 30 2001
Study First Post Date:
2001-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-05
Last Update Post Date:
2017-01-09
Last Update Post Date Type:
ESTIMATED